Posted in Colorectal Cancer • Tags: Cancer_Treatment, Colorectal_Cancer, Erbitux • Author: HART (1-800-HART)
One of the world’s most costly cancer drugs will not be marketed in Canada because of a price dispute between the drug’s distributor and the federal government.
The colorectal cancer drug Erbitux, which was approved by Health Canada nine months ago, will not be launched after distributor Bristol Myers Squibb Canada could not agree on a price with the federal Patented Medicine Prices Review Board., The Globe and Mail reports.
…..
More →
Posted on June 19, 2006 by HART (1-800-HART) • There are no comments, hop to it!
Posted in Chemotherapy • Tags: Cancer_Treatment, Chemotherapy • Author: HART (1-800-HART)
Last Updated: Friday, 31 March 2006, 11:35 GMT 12:35 UK
A new device for cancer patients could end the side effects of chemotherapy such as hair loss and vomiting, researchers say.
The revolutionary new method uses an implant made of tiny fibres and beads soaked in chemotherapy drugs.
The device, which was developed at Bath University, dissolves internally, releasing the chemotherapy chemicals directly into the cancer site.
More →
Posted on April 3, 2006 by HART (1-800-HART) • There are 2 comments!